Why did EXOT choose Exosome Technology as our flagship frontier? 🧬 The numbers speak for themselves: • Market Growth: Projected to grow from $380M in 2024 to $2.28B by 2030. • CAGR: A remarkable 32.1% annual growth rate, outpacing most biotech sectors. •

Can saving lives generate high financial returns? With the Impact-Alpha Flywheel, yes. ⚙️💎 EXOT’s core growth engine: • Impact — funding clinical trials for intractable diseases • Alpha — clinical success exponentially increases the value of biotech equity •

🥂 As 2025 comes to a close, we thank our community for joining the #DeSci revolution. We aren't just ending a year; we are preparing for a massive 2026. From forming our expert SIC committee to executing our first pilot investment, the bedrock is being laid. 🧬🏗️ 🗓 What’s

🎊 Happy New Year 2026! 2025 was about the narrative — 2026 will be about Real-World Impact. This year, move your portfolio beyond hype and speculation. With EXOT, you’re investing in: 🧬 Tangible Biotech Assets — Exosome technology with real-world utility 🔒 Verifiable Trust

$EXOT is more than a token — it’s your key to the DAO Treasury Staking Pool. 🗝️🧬 Here’s how it works — follow the flow: 1️⃣ Stake: Put $EXOT into approved biotech projects. 2️⃣ Fund: Biotech companies use the capital to fuel life-saving breakthroughs. 3️⃣ Earn: Receive yields

Not all governance is created equal. EXOT introduces a hybrid governance model that combines decentralization with expert-driven execution. Through the EXOT DAO, token holders collectively shape key protocol decisions and the future of the ecosystem. Built for transparency.

Building a decentralized biotech ecosystem raises an important question, who decides what comes next? 🤔 At EXOT, that responsibility belongs to the EXOT DAO, where every EXOT token holder participates in shaping the protocol 🧬 The DAO exists to ensure that no single entity

The countdown has officially begun. ⏳ Only 5 DAYS LEFT to join the EXOT Pre-TGE Airdrop. This isn’t just a reward – it’s your entry ticket to the 2026 #DeSci revolution. 200,000 $EXOT tokens are waiting for their rightful owners. 🧬💰 Your Monday mission: 1️⃣ Open the Telegram

Innovation is nothing without Compliance. 🛡️🌐 EXOT isn't just building tech; we are building a regulated bridge for Biotech RWAs. Our infrastructure is reinforced by: • Global KYC/AML: Ensuring a safe environment for all participants. • zk-SNARKs: Protecting data privacy

Is it really possible to bring biotech equity fully on-chain?” 🤔🧬 At EXOT, we’re not asking if we’re building the answer. Our ecosystem runs on a next-generation DeSci × RWA hybrid model, directly linking real-world biotech equity to an on-chain token economy 🔗 ▪️Every

Who decides which life-saving research gets funded on EXOT? 🧐🧬 Meet the SIC (Scientific & Investment Committee). Our rigorous 3-step vetting process ensures only high-potential assets enter the treasury: 1️⃣ Scientific Peer Review: Evaluating the medical breakthrough

Most biotech breakthroughs don’t fail in the lab they fail in funding.” 🧪 EXOT is changing that. We bridge real-world biotech equity with a DeSci × RWA on-chain economy, aligning capital, builders, and community into a single value loop 🔗 When incentives align, outcomes

What does it mean to hold $EXOT? It’s more than a ticker—it’s Ownership. 🔑🏢 As an $EXOT holder, you unlock: 🗳️ Governance: Vote on key SIC investment proposals. 💰 Staking Yields: Direct participation in Biotech RWA growth. 📊 Transparency: Real-time NAV tracking on the

EXOT will operate in alignment with key global regulatory bodies across biotech and financial systems, ensuring research integrity, lawful data utilization, and a compliant token framework. This approach strengthens transparency, protects participants, and positions EXOT for

Markets evolve when narratives collide. DeSci is unlocking science. RWA is bringing real value on-chain. ESG is redefining capital allocation. EXOT sits where these three forces converge, creating a new alternative built for transparency, impact, and scale. 2025 is the

Sustainability isn’t an afterthought, it’s the foundation. 🧱 EXOT is built on a diversified, sustainable revenue model designed to grow long-term ecosystem value. All revenue, after foundation operating costs, flows directly into the DAO Treasury and is reinvested to fuel

This is how real value cycles back. 🧬 The EXOT Buyback Program goes beyond a simple repurchase model, it's a structural value engine that channels biotech investment performance directly into the token economy. Designed to strengthen the ecosystem through: 🔹 Long-term

EXOT’s Technical Vision 🧠⚙️ Built for the future on three core pillars: 🔹 Modularity: Independent modules for governance, RWA tokenization & data management, making upgrades seamless and future-ready. 🔹 Scalability: Powered by BSC with ~$0.01 tx fees and ~3s block times,

Token Value Accrual Mechanisms powering $EXOT 🚀 🔹 NAV Growth: As our portfolio companies grow, the intrinsic value of EXOT grows with them. 🔹 Buy-Back: 10% to 50% of profits from investment exits are used to buy back EXOT from the market. 🔹 Protocol-Owned Liquidity (POL):